SHARES PURCHASE AGREEMENTShares Purchase Agreement • February 10th, 2016 • Cellular Biomedicine Group, Inc. • Biological products, (no disgnostic substances)
This SHARES PURCHASE AGREEMENT (this “Agreement”), is made and entered into as of February 4, 2016, by and among Cellular Biomedicine Group Inc., a Delaware corporation with its principal place of business at 19925 Stevens Creek Blvd., Suite 100, Cupertino, California 95014 U.S.A. (“the Company”), and Dangdai International Group Co., Limited, a Hong Kong limited liability company with CR# 2273242, with its principal place of business at Suite 1501, Grand Millennium Plaza (Lower Block), 181 Queen's Road Central, Sheung Wan, Hong Kong, PRC SAR (“the Purchaser”).
